Tumour-infiltrating lymphocytes (TILs) are a prognostic marker for hormone receptor (HR)-negative breast cancer and patients with tumours with high TIL infiltration tend to have better outcomes [9–11]. The gene discussed is NR4A1; the disease is neoplasm.